91 related articles for article (PubMed ID: 15224345)
1. Negative growth control of renal cell carcinoma cell by connexin 32: possible involvement of Her-2.
Fujimoto E; Satoh H; Negishi E; Ueno K; Nagashima Y; Hagiwara K; Yamasaki H; Yano T
Mol Carcinog; 2004 Jul; 40(3):135-42. PubMed ID: 15224345
[TBL] [Abstract][Full Text] [Related]
2. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells.
Sato H; Senba H; Virgona N; Fukumoto K; Ishida T; Hagiwara H; Negishi E; Ueno K; Yamasaki H; Yano T
Mol Carcinog; 2007 Mar; 46(3):215-24. PubMed ID: 17186540
[TBL] [Abstract][Full Text] [Related]
3. A Src family inhibitor (PP1) potentiates tumor-suppressive effect of connexin 32 gene in renal cancer cells.
Fujimoto E; Sato H; Nagashima Y; Negishi E; Shirai S; Fukumoto K; Hagiwara H; Hagiwara K; Ueno K; Yano T
Life Sci; 2005 Apr; 76(23):2711-20. PubMed ID: 15792837
[TBL] [Abstract][Full Text] [Related]
4. Connexin32 as a tumor suppressor gene in a metastatic renal cell carcinoma cell line.
Fujimoto E; Sato H; Shirai S; Nagashima Y; Fukumoto K; Hagiwara H; Negishi E; Ueno K; Omori Y; Yamasaki H; Hagiwara K; Yano T
Oncogene; 2005 May; 24(22):3684-90. PubMed ID: 15782139
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Src activity enhances the tumor-suppressive effect of the connexin 32 gene in Caki-1 renal cancer cells.
Fujimoto E; Sato H; Shirai S; Nagashima Y; Virgona N; Hagiwara K; Yamasaki H; Negishi E; Ueno K; Yano T
Oncol Rep; 2006 May; 15(5):1359-65. PubMed ID: 16596211
[TBL] [Abstract][Full Text] [Related]
6. The inhibitory effect of connexin 32 gene on metastasis in renal cell carcinoma.
Sato H; Hagiwara H; Senba H; Fukumoto K; Nagashima Y; Yamasaki H; Ueno K; Yano T
Mol Carcinog; 2008 Jun; 47(6):403-9. PubMed ID: 18058801
[TBL] [Abstract][Full Text] [Related]
7. Connexin 32 down-regulates the fibrinolytic factors in metastatic renal cell carcinoma cells.
Hagiwara H; Sato H; Shirai S; Kobayashi S; Fukumoto K; Ishida T; Seki T; Ariga T; Yano T
Life Sci; 2006 Apr; 78(19):2249-54. PubMed ID: 16289236
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of connexin 32 gene by 5-aza-2'-deoxycytidine enhances vinblastine-induced cytotoxicity in human renal carcinoma cells via the activation of JNK signalling.
Takano Y; Iwata H; Yano Y; Miyazawa M; Virgona N; Sato H; Ueno K; Yano T
Biochem Pharmacol; 2010 Aug; 80(4):463-70. PubMed ID: 20510207
[TBL] [Abstract][Full Text] [Related]
9. Connexin 32 expression reduces malignant phenotype in human A549 adenocarcinoma cells: Implication of Src involvement.
Hada S; Sato H; Virgona N; Hagiwara H; Saito T; Suzuki K; Asano R; Yano T
Oncol Rep; 2006 Nov; 16(5):1149-54. PubMed ID: 17016607
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix.
Inamoto T; Yamochi T; Ohnuma K; Iwata S; Kina S; Inamoto S; Tachibana M; Katsuoka Y; Dang NH; Morimoto C
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3470-7. PubMed ID: 16740772
[TBL] [Abstract][Full Text] [Related]
11. Induction of the connexin 32 gene by epigallocatechin-3-gallate potentiates vinblastine-induced cytotoxicity in human renal carcinoma cells.
Sato A; Sekine M; Kobayashi M; Virgona N; Ota M; Yano T
Chemotherapy; 2013; 59(3):192-9. PubMed ID: 24335094
[TBL] [Abstract][Full Text] [Related]
12. Enhancing effect of connexin 32 gene on vinorelbine-induced cytotoxicity in A549 lung adenocarcinoma cells.
Sato H; Fukumoto K; Hada S; Hagiwara H; Fujimoto E; Negishi E; Ueno K; Yano T
Cancer Chemother Pharmacol; 2007 Aug; 60(3):449-57. PubMed ID: 17569045
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Ki-67 in a renal cell carcinoma severe combined immunodeficiency disease mouse model is associated with induction of apoptosis and tumour growth inhibition.
Kausch I; Jiang H; Ewerdwalbesloh N; Doehn C; Krüger S; Sczakiel G; Jocham D
BJU Int; 2005 Feb; 95(3):416-20. PubMed ID: 15679806
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of the CpG island of connexin 32, a candiate tumor suppressor gene in renal cell carcinomas from hemodialysis patients.
Yano T; Ito F; Kobayashi K; Yonezawa Y; Suzuki K; Asano R; Hagiwara K; Nakazawa H; Toma H; Yamasaki H
Cancer Lett; 2004 May; 208(2):137-42. PubMed ID: 15142671
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological inhibitor of fatty acid synthase suppresses growth and invasiveness of renal cancer cells.
Horiguchi A; Asano T; Asano T; Ito K; Sumitomo M; Hayakawa M
J Urol; 2008 Aug; 180(2):729-36. PubMed ID: 18555493
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic effect of the Her-2/Her-1 inhibitor PKI-166 on renal cancer cells expressing the connexin 32 gene.
Fujimoto E; Yano T; Sato H; Hagiwara K; Yamasaki H; Shirai S; Fukumoto K; Hagiwara H; Negishi E; Ueno K
J Pharmacol Sci; 2005 Feb; 97(2):294-8. PubMed ID: 15699574
[TBL] [Abstract][Full Text] [Related]
17. 5-Aza-2'-deoxycytidine suppresses human renal carcinoma cell growth in a xenograft model via up-regulation of the connexin 32 gene.
Hagiwara H; Sato H; Ohde Y; Takano Y; Seki T; Ariga T; Hokaiwado N; Asamoto M; Shirai T; Nagashima Y; Yano T
Br J Pharmacol; 2008 Apr; 153(7):1373-81. PubMed ID: 18264126
[TBL] [Abstract][Full Text] [Related]
18. Connexin-32 acts as a downregulator of growth of thyroid gland.
Prost G; Bernier-Valentin F; Munari-Silem Y; Selmi-Ruby S; Rousset B
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E291-9. PubMed ID: 18042666
[TBL] [Abstract][Full Text] [Related]
19. Targeting beta2-microglobulin mediated signaling as a novel therapeutic approach for human renal cell carcinoma.
Nomura T; Huang WC; Seo S; Zhau HE; Mimata H; Chung LW
J Urol; 2007 Jul; 178(1):292-300. PubMed ID: 17499801
[TBL] [Abstract][Full Text] [Related]
20. 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
Matsuyama M; Yoshimura R; Mitsuhashi M; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
Oncol Rep; 2005 Jul; 14(1):73-9. PubMed ID: 15944770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
